Ocul stock price target
The average price target is $3.63 with a high forecast of $5.00 and a low forecast of $2.25. The average price target represents a 599.42 % increase from the last price of $0.51. Detailed list of analyst forecasts OCULAR THERAPEUTIX, INC. : OCUL Stock Price | MarketScreener Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. OCUL: Ocular Therapeutix, Inc. - Price & Consenus Chart ... OCUL: Ocular Therapeutix, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Ocular Therapeutix, Inc. from Zacks Investment Research Ocular Therapeutix Price Target | OCUL
Mar 24, 2020 · Online Stock Comparison - Compare Ocular Therapeutix, Inc. (OCUL) to four other stocks with NASDAQ.com's stock comparison tool.
Mar 04, 2020 · Add OCUL Price Alert Hide Sticky Hide Intro Moderator: Search This Board: 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+ Ocular Therapeutix Inc., OCUL Quick Chart - (NAS) OCUL ...
Oct 31, 2019 · OCUL, Ocular Therapeutix Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Ocular Therapeutix Inc Stock Quote: OCUL Stock News, Quotes, Analysis | Investors.com
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.
Ocular Therapeutix (NASDAQ:OCUL) had its price objective upped by Piper Sandler from to in a report published on Monday, The Fly reports. A number of other equities analysts have also recently commented on OCUL. HC Wainwright reissued a positive rating and set a $8.00 price target (up previously from $6.00) on shares of Ocular Therapeutix […]
What Are These 2 Stocks Telling Us? – Ocular Therapeutix ... Mar 11, 2020 · The analysts offering the recommendations for the stock have a consensus rating of 2.00 to suggest that the OCUL stock is a “Moderate Sell”. The stock currently trades at $6.17 and analysts tracking its performance over the next 12 months have a consensus estimate price target of $8.80.
Ocular Therapeutix, Inc. (OCUL) Stock Price, Quote ...
Mar 04, 2020 · Add OCUL Price Alert Hide Sticky Hide Intro Moderator: Search This Board: 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+
- usd jpy prix au comptant
- sagd oil sands process
- td交易账户tfsa
- varejo bancário on-line pnb
- td ameritrade futures initial margin
- futuro del dólar vs rupia pakistaní
- geyruwh
- geyruwh
- geyruwh